SynKIR-310 for Relapsed/Refractory B-NHL
מצבים רפואיים
B Cell Lymphoma · NHL, Adult · Mantle Cell Lymphoma · Relapsed Non-Hodgkin Lymphoma · Refractory Non-Hodgkin Lymphoma · Aggressive B-Cell Non-Hodgkin Lymphoma · Indolent B-Cell Non-Hodgkin Lymphoma · Follicular Lymphoma · Marginal Zone Lymphoma · DLBCL - Diffuse Large B Cell Lymphoma · HGBL With MYC and BCL2 and/or BCL6 Rearrangements · High-grade B-cell Lymphoma · Diffuse Large B Cell Lymphoma · Large B-cell Lymphoma · T-Cell/Histiocyte Rich Lymphoma · Non-hodgkin Lymphoma,B Cell · Primary Mediastinal Large B-cell Lymphoma (PMBCL) · Epstein-Barr Virus Positive DLBCL, Nos · Follicular Lymphoma Grade 3B · DLBCL (Diffuse Large B-Cell Lymphoma) Associated With Chronic Inflammation · High Grade B-Cell Lymphoma, Not Otherwise Specified · Follicular Lymphoma Grade 3 · Marginal Zone Splenic Lymphoma · DLBCL · Waldenstrom Macroglobulinemia · Waldenstrom Macroglobulinaemia
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute, Denver, Colorado, United States
Contact: Principal Investigator (Michael T. Tees, MD)Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
Contact: Principal Investigator (Edmund Waller, MD, PhD)The University of Kansas Cancer Center, Fairway, Kansas, United States
Contact: Principal Investigator (Joseph McGuirk, DO)Rutgers Cancer Institute, New Brunswick, New Jersey, United States
Contact: Study coordinator (Hem/Onc Clinical Trial Lab Manager) · tn293@cinj.rutgers.edu · 732-235-7315Contact: Principal Investigator (Matthew Matasar, MD)Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Stephen Schuster, MD)
מובילי המחקר
Laura A Johnson, PhD
Study Chair
Verismo Therapeutics